Gene · 435
Papers1,794
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,794
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic value of magnetic resonance parametric mapping for non-invasive assessment of liver fibrosis in patients with primary sclerosing cholangitis. | BMC Med Imaging | 2021 | 33827475 | PubTator, text mining | PubMed |
| Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines. | Cancers (Basel) | 2021 | 33809510 | PubTator, text mining | PubMed |
| Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia. | Cancer Med | 2021 | 33787078 | PubTator, text mining | PubMed |
| Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME). | Sci Rep | 2021 | 33782445 | PubTator, text mining | PubMed |
| Malic enzyme 2 connects the Krebs cycle intermediate fumarate to mitochondrial biogenesis. | Cell Metab | 2021 | 33770508 | PubTator, text mining | PubMed |
| Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods. | Front Genet | 2021 | 33767726 | PubTator, text mining | PubMed |
| Metabolic alterations and vulnerabilities in hepatocellular carcinoma. | Gastroenterol Rep (Oxf) | 2021 | 33747521 | PubTator, text mining | PubMed |
| Integrated Protein-Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma. | Front Cell Dev Biol | 2021 | 33718368 | PubTator, text mining | PubMed |
| RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma. | Front Oncol | 2021 | 33718217 | PubTator, text mining | PubMed |
| Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies. | Br J Cancer | 2021 | 33674736 | PubTator, text mining | PubMed |
| Nitric oxide and bone: The phoenix rises again. | J Clin Invest | 2021 | 33645546 | PubTator, text mining | PubMed |
| Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients. | Asian Pac J Cancer Prev | 2021 | 33639675 | PubTator, text mining | PubMed |
| Physical, cognitive, and social status of patients with urea cycle disorders in Japan. | Mol Genet Metab Rep | 2021 | 33614409 | PubTator, text mining | PubMed |
| Identification of rare variants causing urea cycle disorders: A clinical, genetic, and biophysical study. | J Cell Mol Med | 2021 | 33611823 | PubTator, text mining | PubMed |
| Tandem Mass Tag-Based Proteomic Analysis of Potential Biomarkers for Hepatocellular Carcinoma Differentiation. | Onco Targets Ther | 2021 | 33603407 | PubTator, text mining | PubMed |
| Prenatal detection of a 7q11.21 microdeletion (517-605 kb): A variant with normal characteristics at birth (STROBE). | Medicine (Baltimore) | 2021 | 33578551 | PubTator, text mining | PubMed |
| Rare genetic variants affecting urine metabolite levels link population variation to inborn errors of metabolism. | Nat Commun | 2021 | 33574263 | PubTator, text mining | PubMed |
| Superresolution characterization of core centriole architecture. | J Cell Biol | 2021 | 33533934 | PubTator, text mining | PubMed |
| Spectrum analysis of inborn errors of metabolism for expanded newborn screening in a northwestern Chinese population. | Sci Rep | 2021 | 33514801 | PubTator, text mining | PubMed |
| A deep intronic variant is a common cause of OTC deficiency in individuals with previously negative genetic testing. | Mol Genet Metab Rep | 2021 | 33489762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/435/papers?page=26